Hubei Goto Biopharm Co.,Ltd. (300966.SZ)
CNY 16.06
(1.58%)
CNY 16.06
(1.58%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 96.57 Million CNY | -2.27% |
| 2022 | 85.28 Million CNY | 2.18% |
| 2021 | 83.47 Million CNY | 105.07% |
| 2020 | 40.7 Million CNY | 4.79% |
| 2019 | 38.84 Million CNY | -12.31% |
| 2018 | 44.29 Million CNY | 10.77% |
| 2017 | 39.98 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 27.34 Million CNY | 41.99% |
| 2024 Q1 | 21.48 Million CNY | 20.02% |
| 2024 Q2 | 20.01 Million CNY | -6.84% |
| 2023 FY | 83.35 Million CNY | -2.27% |
| 2023 Q3 | 22.37 Million CNY | 4.57% |
| 2023 Q4 | 17.9 Million CNY | -20.0% |
| 2023 Q1 | 21.67 Million CNY | -19.53% |
| 2023 Q2 | 21.39 Million CNY | -1.29% |
| 2022 Q2 | 17.81 Million CNY | 3.21% |
| 2022 Q1 | 17.25 Million CNY | -41.29% |
| 2022 FY | 85.28 Million CNY | 2.18% |
| 2022 Q4 | 26.94 Million CNY | 15.72% |
| 2022 Q3 | 23.27 Million CNY | 30.7% |
| 2021 Q1 | 15.15 Million CNY | 112.14% |
| 2021 FY | 83.47 Million CNY | 105.07% |
| 2021 Q4 | 29.39 Million CNY | 46.98% |
| 2021 Q3 | 19.99 Million CNY | 5.66% |
| 2021 Q2 | 18.92 Million CNY | 24.91% |
| 2020 Q4 | -124.81 Million CNY | 52.0% |
| 2020 Q3 | -260.02 Million CNY | -2441.37% |
| 2020 Q2 | 11.1 Million CNY | 84.14% |
| 2020 Q1 | 6.03 Million CNY | 106.01% |
| 2020 FY | 40.7 Million CNY | 4.79% |
| 2019 Q4 | -100.33 Million CNY | 0.0% |
| 2019 FY | 38.84 Million CNY | -12.31% |
| 2018 FY | 44.29 Million CNY | 10.77% |
| 2017 FY | 39.98 Million CNY | 0.0% |